IP Library Granted Patent US 9,629,368
Granted Patent B2
US 9,629,368 · App. 14/204,748 · Granted Apr 25, 2017

Antimicrobial compositions and methods of use

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,629,368
App. No.
14/204,748
Granted
Apr 25, 2017
Kind
B2
Abstract

In one aspect, compositions provide antimicrobial therapy as topical disinfectants. Particularly, one aspect relates to an alcohol containing antimicrobial composition that includes at least one paraben, a redox compound and an organic acid at a concentration of from about 1.5 percent to about 10 percent by weight, based on the total weight of the composition. In other aspects, antimicrobial compositions are used to topically sanitize wounds, skin areas and/or to disinfect surgical instruments or other surfaces. Still, in further aspects, methods, devices and kits relating to an antimicrobial composition are provided.

Claims (14)

1. A method of disinfecting a skin surface comprising applying an antimicrobial composition to a skin surface to be disinfected, wherein the antimicrobial composition comprises (a) ethanol, isopropyl alcohol, n-propanol, or mixture thereof, (b) about 1.5% to 15% by weight citric acid, (c) about 0.01% to about 1% by weight paraben, and (d) about 0.01% to about 0.2% methylene blue.

2. The method of claim 1 , wherein the composition comprises methyl paraben at a concentration of from about 0.1% to about 0.4% by weight, and propyl paraben at a concentration of from about 0.01% to about 0.2% by weight.

3. The method of claim 1 , wherein the composition comprises about 0.03% to about 0.12% by weight methylene blue.

4. The method of claim 1 , wherein the composition comprises about 4% to about 8% by weight citric acid.

5. The method of claim 1 , wherein the composition comprises about 0.2% to about 0.9% by weight sodium citrate.

6. The method of claim 1 , wherein the composition comprises (a) ethanol, isopropyl alcohol, n-propanol, or mixture thereof, (b) about 4% to 8% by weight citric acid, (c) about 0.03% to about 0.09% by weight methylene blue, (d) about 0.1% to about 0.4% by weight methyl paraben, (e) about 0.01% to about 0.2% by weight propyl paraben, and (f) about 0.2% to about 0.9% by weight sodium citrate.

7. The method of claim 1 , wherein the composition has a pH of about 3 to about 7.

8. The method of claim 1 , wherein the composition is contained within an applicator comprising an absorbent material.

9. The method of claim 1 , wherein the applicator comprises a handle portion comprising a chamber for housing the antimicrobial composition, and an applicator portion comprising an absorbent material in fluid communication with the handle portion.

10. The method of claim 1 , wherein the skin surface is an open soft tissue wound.

11. The method of claim 1 , wherein the skin surface is a mucosal surface.

12. The method of claim 1 , wherein applying comprises scrubbing the skin surface with the antimicrobial composition for up to sixty seconds.

13. The method of claim 1 further comprising heating the antimicrobial composition before applying the composition to the skin surface.

14. A method of disinfecting a surgical instrument comprising submerging the surgical instrument in an antimicrobial composition comprising (a) ethanol, isopropyl alcohol, n-propanol, or mixture thereof, (b) about 1.5% to 15% by weight citric acid, (c) about 0.01% to about 1% by weight paraben, and (d) about 0.01% to about 0.2% methylene blue.

Assignments (3)
SECURITY INTEREST Recorded Dec 30, 2021
From: ZUREX PHARMA, INC.
To: WESTERN ALLIANCE BANK
Reel/Frame 058504/0838 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 12, 2014
From: ASH, STEPHEN R.; STECZKO, JANUSZ
To: ASH ACESS TECHNOLOGY, INC.
Reel/Frame 033092/0641 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 12, 2014
From: ASH ACCESS TECHNOLOGY, INC.
To: ZUREX PHARMA, INC.
Reel/Frame 033092/0667 →